Clinical Outcome and Antibiotic Dosing Differences by Weight in Children With Acute Osteomyelitis

Kathryn E Kyler1,2, Brian R Lee3, Earl F Glynn3

  • 1Children's Mercy Kansas City, Kansas City, Missouri kekyler@cmh.edu.

Hospital Pediatrics
|October 1, 2021
PubMed

Insights

Children with overweight and obesity hospitalized for acute hematogenous osteomyelitis (AHO) had higher procedure rates and longer hospital stays. They also received lower weight-based antibiotic doses, indicating weight should guide AHO treatment.

Area of Science:

  • Pediatric infectious diseases
  • Clinical outcomes research
  • Antibiotic dosing optimization

Background:

  • Acute hematogenous osteomyelitis (AHO) is a bone infection in children.
  • Weight status may influence clinical outcomes and treatment of AHO.
  • Current antibiotic dosing practices may not adequately account for weight variations.

Purpose of the Study:

  • To investigate weight-based differences in clinical outcomes for pediatric AHO.
  • To assess antibiotic dosing variability among children with AHO across different weight categories.

Main Methods:

  • Retrospective cohort study of 755 children (2-17 years) with AHO (2010-2017).
  • Weight categories: healthy, overweight, obesity based on CDC BMI percentiles.
  • Comparison of procedure rates, complications, length of stay (LOS), and initial weight-adjusted antibiotic doses.

Main Results:

  • Overweight and obese children had higher rates of surgical procedures (19%, 17%) vs. healthy weight (10%).
  • Longer LOS observed in overweight (5.7 days) and obese (5.8 days) children compared to healthy weight (4.9 days).
  • Higher weight categories received lower mean weight-adjusted daily antibiotic doses.

Conclusions:

  • Children with overweight/obesity and AHO face increased procedures and longer LOS.
  • Weight-based antibiotic dosing was lower in higher weight categories.
  • Clinical management of pediatric AHO should incorporate patient weight considerations.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
46
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
75
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
22
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
201
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
32